The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,6-Difluoro-N-(6-trifluoromethoxybenzothiazol-2-yl)benzamide ID: ALA2235010
PubChem CID: 13798350
Max Phase: Preclinical
Molecular Formula: C15H7F5N2O2S
Molecular Weight: 374.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nc2ccc(OC(F)(F)F)cc2s1)c1c(F)cccc1F
Standard InChI: InChI=1S/C15H7F5N2O2S/c16-8-2-1-3-9(17)12(8)13(23)22-14-21-10-5-4-7(6-11(10)25-14)24-15(18,19)20/h1-6H,(H,21,22,23)
Standard InChI Key: LZLIFADRNLXYDB-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.1683 -17.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1671 -17.9681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8752 -18.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8734 -16.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3629 -16.8873 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.5820 -17.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5846 -17.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3720 -18.2226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8510 -17.5509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6681 -17.5465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0729 -16.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6606 -16.1290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4616 -16.7399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4617 -15.9228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8901 -16.8281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3018 -17.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1182 -17.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5230 -16.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1053 -16.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2902 -16.1189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8745 -15.4154 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1694 -15.5142 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.7540 -15.5141 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.4557 -15.1015 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.8971 -18.2435 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
6 7 1 0
5 6 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
1 13 1 0
13 14 1 0
11 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
20 21 1 0
14 22 1 0
14 23 1 0
14 24 1 0
16 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.29Molecular Weight (Monoisotopic): 374.0148AlogP: 4.73#Rotatable Bonds: 3Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.53CX Basic pKa: ┄CX LogP: 5.61CX LogD: 5.60Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -2.31
References 1. Caputo R, Calabro ML, Micale N, Schimmer AD, Ali M, Zappala M, Grasso S. (2012) Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents, 21 (9): [10.1007/s00044-011-9789-8 ]